October 27, 2026
Unraveling Cancer’s Devious Strategy: OU Researchers Discover How Aggressive Tumors Hijack the Immune System to Fuel Growth unraveling-cancers-devious-strategy-ou-researchers-discover-how-aggressive-tumors-hijack-the-immune-system-to-fuel-growth

Unraveling Cancer’s Devious Strategy: OU Researchers Discover How Aggressive Tumors Hijack the Immune System to Fuel Growth

Neng Nana October 21, 2026
NORMAN, OK – In a significant breakthrough poised to redefine our understanding of cancer progression and treatment,...
Read More Read more about Unraveling Cancer’s Devious Strategy: OU Researchers Discover How Aggressive Tumors Hijack the Immune System to Fuel Growth
Duvakitug Emerges as a Promising Contender in the Inflammatory Bowel Disease Race, Analysts Highlight Differentiating Factors duvakitug-emerges-as-a-promising-contender-in-the-inflammatory-bowel-disease-race-analysts-highlight-differentiating-factors

Duvakitug Emerges as a Promising Contender in the Inflammatory Bowel Disease Race, Analysts Highlight Differentiating Factors

Nana Muazin October 21, 2026
Sanofi and Teva Pharmaceuticals’ investigational therapy, duvakitug, has demonstrated significant clinical benefits in patients suffering from moderate-to-severe...
Read More Read more about Duvakitug Emerges as a Promising Contender in the Inflammatory Bowel Disease Race, Analysts Highlight Differentiating Factors
A New Frontier in Hepatology: FDA Greenlights GSK’s Hibsago as Potential ‘Functional Cure’ for Hepatitis B a-new-frontier-in-hepatology-fda-greenlights-gsks-hibsago-as-potential-functional-cure-for-hepatitis-b

A New Frontier in Hepatology: FDA Greenlights GSK’s Hibsago as Potential ‘Functional Cure’ for Hepatitis B

Asep Darmawan October 21, 2026
By Delilah Alvarado Published: October 21, 2026 In a landmark decision that promises to reshape the landscape...
Read More Read more about A New Frontier in Hepatology: FDA Greenlights GSK’s Hibsago as Potential ‘Functional Cure’ for Hepatitis B
The New Frontier: Roche and Hansoh Pharma’s $400M Strategic Alliance Signals Shift in Oncology R&D the-new-frontier-roche-and-hansoh-pharmas-400m-strategic-alliance-signals-shift-in-oncology-rd

The New Frontier: Roche and Hansoh Pharma’s $400M Strategic Alliance Signals Shift in Oncology R&D

Nila Kartika Wati October 21, 2026
In a move that underscores the evolving landscape of global biopharmaceutical research, Swiss pharmaceutical giant Roche has...
Read More Read more about The New Frontier: Roche and Hansoh Pharma’s $400M Strategic Alliance Signals Shift in Oncology R&D
A New Dawn for Reproductive Medicine: Eight Healthy Infants Born via Pioneering Mitochondrial Donation a-new-dawn-for-reproductive-medicine-eight-healthy-infants-born-via-pioneering-mitochondrial-donation-7

A New Dawn for Reproductive Medicine: Eight Healthy Infants Born via Pioneering Mitochondrial Donation

Laily UPN October 21, 2026
In a landmark achievement for genomic medicine, researchers at Newcastle University and The Newcastle upon Tyne Hospitals...
Read More Read more about A New Dawn for Reproductive Medicine: Eight Healthy Infants Born via Pioneering Mitochondrial Donation

You may have missed

unraveling-the-gut-heart-connection-a-new-era-in-cardiovascular-disease-prevention

Unraveling the Gut-Heart Connection: A New Era in Cardiovascular Disease Prevention

Dwi Wanna October 27, 2026
esmo26-sac-tmts-optitrop-lung04-survival-gain-holds-putting-the-onus-on-msd

ESMO26: Sac-TMT’s OptiTROP-Lung04 survival gain holds, putting the onus on MSD

Asep Darmawan October 27, 2026
navigating-the-storm-guiding-children-through-a-parents-cancer-recurrence

Navigating the Storm: Guiding Children Through a Parent’s Cancer Recurrence

Jia Lissa October 27, 2026
a-new-era-for-global-health-african-nations-spearhead-landmark-45-million-pledge-to-transform-who-financing

A New Era for Global Health: African Nations Spearhead Landmark $45 Million Pledge to Transform WHO Financing

Layla Zulfa October 27, 2026